Faculty (All Levels)
The newly established Department of Oncology Science, College of Medicine at the University of Oklahoma Health Sciences Center invites applications for ranks of Assistant, Associate, and Full Professor positions. The faculty members will also be affiliated with the NCI-designated OU Health Stephenson Cancer Center and will have access to exceptional resources and opportunities for interdisciplinary collaborations. Individuals with specialty in areas of cancer metabolism, metabolic imaging, cancer signaling, epigenomics, tumor immunology, health disparities, health /lifestyle behaviors and interventions, cachexia, chemical biology, or bioinformatics are encouraged to apply. Selected candidate(s) will be provided competitive salaries and start-up support for a period of 5 years. Salary to be commensurate with experience.
Eligibility:
Individuals working in cancer metabolism, metabolic imaging, cancer signaling, epigenomics, tumor immunology, health disparities, cachexia, chemical biology, or bioinformatics areas of cancer research• Must hold a PhD or MD or MD/PhD degree in any area of biomedical sciences • Demonstrate strong publication record related to cancer in high impact journals• Candidates with funding from NCI, DoD, or ACS are highly encouraged to apply• Possess a strong scientific research program and able to manage independent research
Salary and Start-up Funding:
• The selection committee with recommend the salary for the individual based on the salary range set by the University’s standard.
• Start-up funds amount will be based on recommendation from the selection committee and their review of planned research and goals.
Application Requirements:
• Applicant’s Complete Curriculum Vitae
• Research plan to be undertaken in 3-5 years – (3 pages)
o Research Proposal should be independent of mentor’s research program for the Assistant Professor position
• Teaching statement (up to 2 pages)
• A list of 3-5 professional references with email addresses and phone numbers
Selection Criteria:
• Applications received will be reviewed by a selection committee
• Selected candidates will be invited for an interview and will present their research work and future goals
Appointment begins as early as March 2023. Review of applications will begin in September 2022 and continue until the position is filled.
Complete application package will need to be submitted in PDF format by email to Ms. Rebecca New at Onc-Sci@ouhsc.edu.
The University of Oklahoma Health Sciences Center seeks to recruit and retain a diverse community of health professionals and scholars. We seek a community with a wide range of perspectives and experiences, and we provide equal employment opportunities to qualified applicants without regard to race, color, religion, political beliefs, national origin, age (40 or older), sex (see: Sexual Misconduct, Discrimination policy) sexual orientation, genetic information, gender identity, gender expression, disability, or veteran status.
NIH-funded post-doctoral research fellow position in pancreatic cancer metabolism and multi-omics studies
The Pankaj Singh lab at the newly established Department of Oncology Science and the NCI-designated OU Health Stephenson Cancer Center is recruiting an enthusiastic and motivated postdoctoral researcher to join on an NIH/NCI-funded study on pancreatic cancer metabolism. The research project involves investigating signal transduction and metabolic alterations in pancreatic cancer cells, tumor-stromal crosstalk, therapy resistance, metastasis, and immunometabolism, using cutting-edge technologies and multi-omics platforms. A successful postdoctoral candidate should have a Ph.D. in the relevant field with a strong theoretical background in basic biochemistry and molecular biology and/or human physiology. The candidate should be well versed with basic molecular biology and cell culture techniques. The project also involves utilizing mice models of pancreatic cancer (PDX models and genetically engineered models). Some LC-MS/MS, bioinformatics, and small-animal research experience is preferred but not required. More details about our work can be found in some of our recent publications (Cancer Cell 2017 32(1):71-87; JEM 2020 217 (7):e20190745; PNAS 109(34):13787-92; Immunity 2019 50(3):576-590; Nature Medicine. 2019 25(4):628-640; Gastroenterology 2021 Jul 8:S0016-5085(21)03159-0; Nature Reviews Cancer 2023 Mar 27:1-20).
Our state-of-the art research program utilizes multi-omics approaches, including sc-RNA-seq, bulk RNAseq, epigenomics, metabolomics, proteomics, organoid cultures, and genetically engineered mouse models and organoid models. Our program is well-funded by NCI, with multiple R01 grants, a program project on pancreatic cancer metastasis, and a U54 grant on acquired therapy resistance in pancreatic cancer.
The Singh lab is a friendly, welcoming, and inclusive place with great excitement for cancer research. We plan to complete the recruitment process soon.
Interested candidates should submit their CV directly at Onc-Sci@ouhsc.edu.
The University of Oklahoma Health Sciences Center seeks to recruit and retain a diverse community of health professionals and scholars. We seek a community with a wide range of perspectives and experiences, and we provide equal employment opportunities to qualified applicants without regard to race, color, religion, political beliefs, national origin, age (40 or older), sex (see: Sexual Misconduct, Discrimination policy) sexual orientation, genetic information, gender identity, gender expression, disability, or veteran status.
Postdoctoral Research Associate
The Kamiya Mehla lab at the newly established Department of Oncology Science and the NCI-designated OU Health Stephenson Cancer Center is recruiting an enthusiastic and motivated postdoctoral researcher to join on an NIH/NCI-funded study on cancer immunotherapy and immunometabolism. The postdoctoral researcher will be working in a multidisciplinary research group to study novel aspects of immunometabolism, tumor-immune cell interactions at the primary tumor and systemic sites in pancreatic cancer. Our state-of-the art research program utilizes molecular biology and immunology techniques along with multi-omics approaches, including sc-RNA-seq, bulk RNAseq, epigenomics, metabolomics, proteomics, CRISPR screens and genetically engineered mouse models and organoid models of pancreatic cancer.
The ideal candidate should possess a Ph.D or M.D./Ph.D in the field of Immunology/ Molecular Biology/ Cancer Biology/ Biochemistry or a related field with expertise in cell-based assays, and/or animal studies. For more detail, please refers to our recent articles (Oncogene. 2022, Trends Immunol. 2022, Gastroenterology 2021, JEM 2020). The Mehla lab is a friendly, welcoming, and inclusive place with great excitement for cancer research. Our future research objectives include, but are not limited to, cell-based therapeutics.
Interested candidates should submit their CV directly to Dr. Mehla at kamiya-mehla@ouhsc.edu
The University of Oklahoma Health Sciences Center seeks to recruit and retain a diverse community of health professionals and scholars. We seek a community with a wide range of perspectives and experiences, and we provide equal employment opportunities to qualified applicants without regard to race, color, religion, political beliefs, national origin, age (40 or older), sex (see: Sexual Misconduct, Discrimination policy) sexual orientation, genetic information, gender identity, gender expression, disability, or veteran status.
Post-Doctoral Fellow
Hsieh MH et. al. p63 and SOX2 Dictate Glucose Reliance and Metabolic Vulnerabilities in Squamous Cell Carcinomas. Cell Reports. 2019;28(7):1860-78 e9.
Goodwin J et. al. Targeting Hypoxia-Inducible Factor-1alpha/Pyruvate Dehydrogenase Kinase 1 Axis by Dichloroacetate Suppresses Bleomycin-induced Pulmonary Fibrosis. Am J Respir Cell Mol Biol. 2018;58(2):216-31.
Goodwin J et. al. The distinct metabolic phenotype of lung squamous cell carcinoma defines selective vulnerability to glycolytic inhibition. Nature Communications. 2017;8:15503.
Lee YS, Kim JW et. al. Increased adipocyte O2 consumption triggers HIF-1alpha, causing inflammation and insulin resistance in obesity. Cell. 2014;157(6):1339-52.
Required qualifications
Post-doctoral Fellow: The position is available for a highly enthusiatistic and motivated candidates who have published experience in cancer metabolism, tumor microenvironment and other metabolic diseases such as obesity and diabetes. Ability to design and perform experiments, and excellent communication and writing skills are required.
Qualified candidates are invited to send the following materials:
The Kim lab is a friendly, welcoming, and inclusive place with great excitement for cancer research. We plan to complete the recruitment process soon.
Interested candidates should submit their CV directly to Ms. Rebecca New at Onc-Sci@ouhsc.edu.
The University of Oklahoma Health Sciences Center seeks to recruit and retain a diverse community of health professionals and scholars. We seek a community with a wide range of perspectives and experiences, and we provide equal employment opportunities to qualified applicants without regard to race, color, religion, political beliefs, national origin, age (40 or older), sex (see: Sexual Misconduct, Discrimination policy) sexual orientation, genetic information, gender identity, gender expression, disability, or veteran status.
NIH-funded and Department of Defense (DoD)-funded projects post-doctoral research fellow positions in Regulatory RNA Research.
The Je-Hyun Yoon lab at the newly established Department of Oncology Science and the NCI-designated OU Health Stephenson Cancer Center is recruiting enthusiastic and motivated postdoctoral researchers to join NIH-funded and Department of Defense (DoD)-funded projects on 1) the alcoholic liver injury and cancer and 2) the Duchenne Muscular Dystrophy studies specifically involving biochemical, molecular, and cellular mechanisms of extracellular RNA release and circular RNA biogenesis. We develop cutting edge projects on 3) Post-transcriptional RNA modifications by small peptides in energy metabolism.
https://grantome.com/grant/NIH/R01-AA027532-01A1
The Yoon Lab possesses a strong track record on noncoding RNA studies including Park et al., 2021 Cell Metabolism and Lee et al., 2022 Nature Communications
https://www.cell.com/cell-metabolism/fulltext/S1550-4131(21)00539-8 https://www.nature.com/articles/s41467-022-32856-2
There is an opportunity to complete ongoing research projects as well.
Duties: Potential research projects involve working in:
1) intestinal epithelial cell and hepatocyte models of alcohol-induced liver inflammation and tumorigenesis.
2) In vitro models of skeletal muscle differentiation and membrane repair modulated by circular RNAs.
3) Biochemical linkage of ribonucleotides and polypeptides driving energy metabolism in cancer and aging.
Successful postdoctoral candidates should be qualified and motivated individuals with a Ph.D. from broad backgrounds in biochemistry, molecular and cellular biology fields, including but not limited to post-transcriptional gene expression regulation. Recently graduated Ph.D.’s from diverse backgrounds are encouraged to apply. The ideal candidate will have an excellent record of publication in peer-reviewed journals.
The Yoon lab is a friendly, welcoming, and inclusive place with great excitement for cancer research. We plan to complete the recruitment process soon.
Interested candidates should submit their CV directly to Ms. Rebecca New at Onc-Sci@ouhsc.edu.
The University of Oklahoma Health Sciences Center seeks to recruit and retain a diverse community of health professionals and scholars. We seek a community with a wide range of perspectives and experiences, and we provide equal employment opportunities to qualified applicants without regard to race, color, religion, political beliefs, national origin, age (40 or older), sex (see: Sexual Misconduct, Discrimination policy) sexual orientation, genetic information, gender identity, gender expression, disability, or veteran status.
Post-Doctoral Research Fellow positions to study epigenetic mechanisms of treatment resistance and tumor-microenvironment interactions in glioblastoma.
The Muthukrishnan lab at the Department of Oncology Science and the NCI-designated OU Health Stephenson Cancer Center is seeking a highly motivated, creative and ambitious postdoctoral fellow to study epigenetic mechanisms of treatment resistance and tumor-microenvironment interactions in glioblastoma. Research projects in this newly established laboratory will focus on 3 key aspects of GBM biology: a) investigating vascular-microglia interactions in mediating GBM immunosuppression, b) understanding molecular mechanisms of therapeutic resistance and plasticity in GBM c) delineating the role of histone acetyltransferases in GBM stem cells. These projects will utilize a combination of patient-derived cells and mouse models, and cutting-edge technologies such as CRISPR, and multi-omics approaches including single-cell and bulk RNA-sequencing, epigenomics, proteomics and spatial transcriptomics to identify potential therapeutics for targeting GBM. For more details, please refer to articles: (Nature communications 2022, https://doi.org/10.1038/s41467-022-33943-0, Cell Reports 2022 10.1016/j.celrep.2022.111511)
The ideal candidate should have a Ph.D. in cancer biology/immunology/molecular biology or a relevant field with a strong background in cell culture, basic and advanced molecular biology techniques. Experience and expertise with mouse models, single cell RNA-sequencing and genomics is highly desired. Candidate should possess excellent written and verbal communication skills, and willingness to learn and implement new techniques. Candidate will be expected to perform research, write manuscripts, submit fellowship applications, assist in grant proposals, and present their findings at local and national meetings.
The Muthukrishnan lab is a friendly, welcoming, and inclusive place with great excitement for cancer research. We plan to complete the recruitment process soon.
Interested candidates should submit their CV, letter of interest, and list of 3 professional references directly to Ms. Rebecca New at Onc-Sci@ouhsc.edu.
The University of Oklahoma Health Sciences Center seeks to recruit and retain a diverse community of health professionals and scholars. We seek a community with a wide range of perspectives and experiences, and we provide equal employment opportunities to qualified applicants without regard to race, color, religion, political beliefs, national origin, age (40 or older), sex (see: Sexual Misconduct, Discrimination policy) sexual orientation, genetic information, gender identity, gender expression, disability, or veteran status.